Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial-Reference-Cited by-同舟云学术

Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial

Published:2024-08 Issue: Volume: Page:
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Pratley Richard E.,Tuttle Katherine R.,Rossing Peter,Rasmussen Søren,Perkovic Vlado,Nielsen Olav Wendelboe,Mann Johannes F.E.,MacIsaac Richard J.,Kosiborod Mikhail N.,Kamenov Zdravko,Idorn Thomas,Hansen Marco Bo,Hadjadj Samy,Bakris George,Baeres Florian M.M.,Mahaffey Kenneth W.

Funder

Novo Nordisk A/S

Publisher

Elsevier BV

Reference28 articles.

1. Global burden of heart failure: a comprehensive and updated review of epidemiology;Savarese;Cardiovasc Res,2023

2. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options;Jankowski;Circulation,2021

3. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data;Matsushita;Lancet Diabetes Endocrinol,2015

4. Reduced kidney function as a risk factor for incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study;Kottgen;J Am Soc Nephrol,2007

5. Renal function, neurohormonal activation, and survival in patients with chronic heart failure;Hillege;Circulation,2000

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European Society of Cardiology Congress 2024 Meeting: Heart Failure Highlights;Journal of Cardiac Failure;2024-09

2. Effects of GLP-1 Receptor Agonists on Heart Failure Outcomes;Journal of the American College of Cardiology;2024-08